Drug Trial Radar · NCT02101359
Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery
Last checked: Nov 20, 2026Latest source record: Nov 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
609
Actual
Start
Jun 2011
Primary completion
Jan 2013
Study completion May 2013
Sponsor
- Lead sponsor
- Laboratoires TheaIndustry
- Sponsor type
- Industry
- First posted
- Apr 2, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years, up to 88 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the efficacy and safety assessment of T2380 for mydriasis and anaesthesia in phacoemulsification cataract surgery versus reference group (topical mydriatics and anaesthetic) 2X246 patients.
Conditions
- Cataract
Interventions
T2380Drug
200 microlitres of T2380 will be administrated intracamerally
MydriaticsDrug
3 drops of tropicamide and phenylephrine were instilled 30 minutes before surgery. The second and the third instillation of both phenylephrine and tropicamide will be realised respectively within 20 and 10 minutes before surgery.
TetracaineDrug
Two drops of tetracaine were instilled in the eye to be operated 5 minutes and 1 minute before surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Primary Efficacy Variable is Response Based on the Realisation of the Capsulorhexis Without Use of Any Additive Mydriatic Treatment.Time frame: Day 0
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Laboratoires Thea
Clermont-Ferrand, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.